If your business invests in research and development, the way you track and document that work has never mattered more. Since the Tax Cuts and Jobs Act of 2017 changed the rules around Section 174, companies can no longer deduct R&D expenses in the year they’re incurred. Instead, those costs must be capitalized and amortized, and if your documentation isn’t up to the task, you could be leaving significant tax benefits on the table or exposing yourself to unnecessary risk.
This guide walks through what Section 174 capitalization means, which expenses it covers, how to identify qualifying activities, and, most importantly, what your documentation needs to look like to stay compliant and defensible.
What Is Section 174 Capitalization
Section 174 of the Internal Revenue Code governs the tax treatment of “specified research or experimental expenditures.” For most of its history, Section 174 allowed businesses to immediately deduct these costs in the year they were paid or incurred. That changed with the Tax Cuts and Jobs Act of 2017, which amended Section 174 to require capitalization of R&D expenses beginning with tax years starting after December 31, 2021.
Under the current rules, domestic R&D expenditures must be capitalized and amortized over five years (15 years for research conducted outside the United States), using a midpoint convention in the first year. This means that rather than receiving a full deduction upfront, businesses recover their R&D costs gradually over the amortization period.
Why the Section 174 Capitalization Rules Matter for Taxpayers
The shift from immediate deductibility to mandatory capitalization has real financial consequences. For businesses that spend heavily on R&D; whether in software development, manufacturing, pharmaceuticals, engineering, or a wide range of other industries; taxable income can increase significantly in the short term, even when the underlying business activity hasn’t changed.
Here’s why this matters beyond the immediate tax hit:
Cash flow impact: Companies that previously reduced their tax liability dollar-for-dollar in the year of spending now face a timing mismatch between when costs are incurred and when deductions are available.
Increased compliance complexity: Section 174 requires taxpayers to identify, categorize, and track qualifying expenditures separately from other business costs. That means more documentation, more nuance, and more risk of error.
Audit exposure: The IRS pays close attention to how businesses classify R&D expenses. Without solid documentation, even legitimate expenditures can be challenged.
Interaction with R&D Tax Credits: Section 174 capitalization and the Section 41 R&D Tax Credit are related but distinct — both rely on identifying qualifying research activities, but they have different definitions, calculation methods, and documentation standards. Getting one right without the other doesn’t fully protect you.
How Section 174 R&D Capitalization Works in Practice
Under current law, the mechanics of Section 174 capitalization work as follows:
When a qualifying R&D expenditure is incurred, it’s capitalized to an intangible asset account rather than expensed immediately. The capitalized amount is then amortized:
- Domestic research: 5-year amortization period, beginning at the midpoint of the tax year in which the expenditure is paid or incurred (effectively a 60-month period starting mid-year one)
- Foreign research: 15-year amortization period, with the same midpoint convention
The midpoint convention means that in the first year, only half a year’s worth of amortization is taken, regardless of when during the year the expenditure occurred. Full amortization deductions are then taken in years two through five (or fifteen), with the remaining half-year deduction in the sixth year.
Example: A company incurs $1,000,000 in domestic Section 174 expenses in 2024. Under capitalization rules, they deduct $100,000 in 2024 (half of the $200,000 annual amortization), $200,000 in each of years 2025 through 2028, and $100,000 in 2029.
What Expenses Must Be Capitalized Under Section 174
Section 174 applies to “specified research or experimental expenditures,” which the IRS defines broadly. Understanding what falls into this category is essential before you can begin documenting it properly.
Generally included expenses:
- Wages and salaries paid to employees who perform, supervise, or support qualified research activities
- Costs of supplies consumed in the research process
- Contract research expenses paid to third parties for research performed on your behalf
- Costs associated with obtaining a patent, including attorneys’ fees
- Amounts paid for research conducted under contract (subject to certain rules)
Generally excluded expenses:
- Expenses for the ordinary testing or inspection of materials or products for quality control
- Efficiency surveys and market research
- Research in connection with literary, historical, or similar projects
- Costs for acquiring another’s patent, model, production, or process
- Expenses for research conducted after the beginning of commercial production of a product
One important note: Section 174’s definition of qualifying expenditures is broader than the definition used for the Section 41 R&D Tax Credit. Expenditures that don’t qualify for the credit may still need to be capitalized under Section 174. This is a nuance that trips up many businesses and underscores the value of working with experienced tax professionals.
How to Identify Qualifying R&D Activities
Before you can document Section 174 expenditures, you need to know which activities generate them. While this sounds straightforward, the boundaries can be less obvious than they appear.
Start with your business operations. Walk through every department, product line, and project to identify where employees or contractors are working to develop, improve, or design products, processes, software, or techniques. If a project involves technical uncertainty, meaning you can’t know at the outset whether the approach will work, it’s worth taking a closer look.
Ask these core questions:
- Is the purpose of this activity to develop or improve a product, process, software, technique, formula, or invention?
- Does the activity involve some level of technological uncertainty, meaning the capability or method to achieve the desired result isn’t readily available?
- Is the activity technological in nature, relying on engineering, computer science, physics, chemistry, biology, or a similar hard science?
If the answer to all three is yes, the activity likely generates Section 174 expenditures. Note that the Section 174 test is less restrictive than the four-part test for the Section 41 R&D credit, you don’t need to satisfy the process of experimentation requirement for Section 174 purposes.
Common activities that often qualify:
- Developing new software functionality or internal-use software
- Engineering design and prototyping
- Formulating new materials, chemicals, or compounds
- Testing and iteration of new products or manufacturing processes
- Clinical or laboratory research
Activities that typically don’t qualify:
- Production and manufacturing of existing products
- Routine data collection or quality testing
- Administrative or support functions unrelated to R&D
- Research for social science or humanities
Documentation Requirements for Section 174 Compliance
This is where many businesses fall short. Even if a company correctly identifies its qualifying R&D activities and captures the right expenses, insufficient documentation can undermine an otherwise valid position. Here’s what strong Section 174 documentation looks like.
Project-Level Documentation
For each R&D project or activity, maintain records that establish:
- Project description: What is being developed, improved, or tested, and what technological problem is being addressed?
- Uncertainty statement: What is unknown at the outset, and what approaches are being evaluated to resolve that uncertainty?
- Technical narrative: A description of the methods, experiments, or development processes being used
- Timeline: Project start and end dates, including milestones and key decision points
- Outcome records: Results of experiments, test data, design iterations, prototypes, or technical reports; including failed attempts, which are evidence of genuine experimentation
Personnel Documentation
- Employee time records: Time allocation records showing which employees worked on qualifying activities and for how long. This doesn’t have to be down to the minute, but it should be reasonably contemporaneous and defensible.
- Job descriptions and responsibilities: Role documentation that confirms an employee’s function in relation to R&D activities
- Supervision and support: Records showing how supervisors and support personnel contributed to qualifying projects
Financial Documentation
- Cost allocation records: Schedules that tie specific expenses; wages, supplies, contractor costs; to qualifying projects
- Contractor agreements and invoices: Contracts and supporting documentation for third-party research, including confirmation that the work qualifies
- Accounting records: General ledger entries, expense reports, and any internal cost accounting systems used to track R&D spending
Consistency and Contemporaneity
One of the most important, and most overlooked, documentation principles is that records should be created at the time the activity occurs, not reconstructed after the fact. Contemporaneous records carry far more weight in an IRS examination than documentation assembled retroactively. Build your documentation practices into day-to-day project management, not year-end tax prep.
Retention
The IRS generally has three years from the filing date to audit a return, but that period can be extended to six years if income is substantially understated, and indefinitely in cases of fraud. A best practice is to retain all Section 174 documentation for at least seven years, and longer for expenditures tied to assets still on your books.
Section 174 Capitalization Repeal Status and Legislative Updates
The business community and tax professionals have pushed back significantly on the Section 174 capitalization requirement since it took effect for tax years beginning after December 31, 2021. Legislation to restore immediate deductibility has been introduced and debated in Congress on multiple occasions.
As of the time of this writing, the mandatory capitalization rules remain in effect, and taxpayers should plan accordingly. While there has been bipartisan support for restoring the prior-law treatment, no permanent fix has been enacted. Any legislative change could be retroactive or prospective, and the specifics would determine whether and how affected taxpayers could amend prior returns.
What this means for your planning:
- Do not assume repeal is imminent or certain, file and document in compliance with current law
- Maintain documentation that positions you to benefit from any retroactive fix if legislation passes
- Work with tax advisors who are actively monitoring legislative developments
- If you haven’t yet caught up on Section 174 compliance for prior open tax years, now is the time to act
CSSI’s team actively tracks legislative updates and can help you stay ahead of changes that affect your R&D tax position.
Conclusion
Section 174 capitalization has fundamentally changed how R&D costs are treated for tax purposes, and the documentation requirements that come with it are not optional, they’re the foundation of a defensible tax position. Whether you’re just getting your arms around these rules or looking to strengthen your existing processes, the key principles are the same: identify qualifying activities early, track costs contemporaneously, and maintain organized records that tell a clear and complete story.
The businesses that will fare best under these rules are the ones that treat documentation as an ongoing operational practice rather than a last-minute tax exercise. If you’re not sure whether your current documentation approach is sufficient, a review by experienced R&D tax specialists can identify gaps before they become problems.
CSSI has spent over two decades helping businesses navigate complex tax strategies, including R&D tax credits and Section 174 compliance, with an engineering-based, audit-ready approach. If you’d like to understand how these rules apply to your business, we’d be glad to take a look.
FAQs
What is the difference between Section 174 and the Section 41 R&D Tax Credit?
Section 174 governs which research expenses must be capitalized and amortized, while Section 41 provides a tax credit for a subset of qualifying research activities. The definitions overlap but are not identical, Section 174 is broader. Expenses can qualify for capitalization under Section 174 without generating a credit under Section 41, and vice versa in some limited circumstances.
Do software development costs qualify under Section 174?
Yes, in most cases. Software development, including internal-use software development, is generally subject to Section 174 capitalization if it meets the definition of specified research or experimental expenditures. This has been a significant issue for technology companies and businesses with in-house software teams.
Can small businesses be affected by Section 174 capitalization?
Yes. There is no small business exemption from Section 174 capitalization. Any business that incurs qualifying R&D expenditures, regardless of size, is subject to these rules.
What happens to capitalized R&D costs if a project is abandoned?
If a project is abandoned before the amortization period ends, the remaining unamortized balance may be deductible as a loss in the year of abandonment, subject to applicable rules. Good project-level documentation makes it easier to establish when a project was abandoned and what the remaining basis was.
Is the Section 174 capitalization requirement permanent?
Under current law, yes, though Congress has debated legislation to restore prior-law immediate deductibility. Taxpayers should continue to comply with the capitalization requirement unless and until a law change is enacted.
How does Section 174 interact with the bonus depreciation rules?
Section 174 expenditures are specifically excluded from the definition of property eligible for bonus depreciation under Section 168(k). The capitalization and amortization rules of Section 174 apply exclusively to qualifying R&D costs.
What if my company didn’t properly capitalize R&D costs in prior years?
If Section 174 was not properly applied in a prior year, there are procedures for correcting the treatment, which may include filing amended returns or seeking a change in accounting method. Acting proactively is almost always preferable to waiting for an IRS inquiry.
How can CSSI help with Section 174 compliance?
CSSI’s R&D tax specialists work with businesses to identify qualifying expenditures, review documentation practices, and ensure your R&D tax position is fully supported and audit-ready. Contact us to learn more about how we can help.
